Skip to Main Content


Skip Nav Destination

Cutting Edge: Tumor-Specific CTL Are Constitutively Cross-Armed in Draining Lymph Nodes and Transiently Disseminate to Mediate Tumor Regression following Systemic CD40 Activation1

J Immunol (2004) 173 (10): 5923–5928.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal